Current understanding of neurofibromatosis type 1, 2, and schwannomatosis
R Tamura - International journal of molecular sciences, 2021 - mdpi.com
Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of
tumors of the central or peripheral nervous system including the brain, spinal cord, organs …
tumors of the central or peripheral nervous system including the brain, spinal cord, organs …
Neurofibromatosis type 1
DH Gutmann, RE Ferner, RH Listernick… - Nature Reviews …, 2017 - nature.com
Neurofibromatosis type 1 is a complex autosomal dominant disorder caused by germline
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …
mutations in the NF1 tumour suppressor gene. Nearly all individuals with neurofibromatosis …
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression
A De Boeck, BY Ahn, C D'Mello, X Lun… - Nature …, 2020 - nature.com
Despite a deeper molecular understanding, human glioblastoma remains one of the most
treatment refractory and fatal cancers. It is known that the presence of macrophages and …
treatment refractory and fatal cancers. It is known that the presence of macrophages and …
IFNγ is critical for CAR T cell–mediated myeloid activation and induction of endogenous immunity
D Alizadeh, RA Wong, S Gholamin, M Maker… - Cancer discovery, 2021 - AACR
Chimeric antigen receptor (CAR) T cells mediate potent antigen-specific antitumor activity;
however, their indirect effects on the endogenous immune system are not well …
however, their indirect effects on the endogenous immune system are not well …
[HTML][HTML] Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge
We have extended our understanding of the molecular biology that underlies adult
glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents …
glioblastoma over many years. By contrast, high-grade gliomas in children and adolescents …
Mouse models of glioblastoma for the evaluation of novel therapeutic strategies
Glioblastoma (GBM) is an incurable brain tumor with a median survival of approximately 15
months despite an aggressive standard of care that includes surgery, chemotherapy, and …
months despite an aggressive standard of care that includes surgery, chemotherapy, and …
Guidelines for the welfare and use of animals in cancer research
P Workman, EO Aboagye, F Balkwill, A Balmain… - British journal of …, 2010 - nature.com
Animal experiments remain essential to understand the fundamental mechanisms
underpinning malignancy and to discover improved methods to prevent, diagnose and treat …
underpinning malignancy and to discover improved methods to prevent, diagnose and treat …
[HTML][HTML] Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue … - Nature, 2008 - nature.com
Human cancer cells typically harbour multiple chromosomal aberrations, nucleotide
substitutions and epigenetic modifications that drive malignant transformation. The Cancer …
substitutions and epigenetic modifications that drive malignant transformation. The Cancer …
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
To understand the relationships between the non-GCIMP glioblastoma (GBM) subgroups,
we performed mathematical modeling to predict the temporal sequence of driver events …
we performed mathematical modeling to predict the temporal sequence of driver events …
Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice
Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain
tumor in humans. Here we show that gliomas can originate from differentiated cells in the …
tumor in humans. Here we show that gliomas can originate from differentiated cells in the …